Ordering
Available Variants5 mg
CHA.29213-5mg
Price
€240.00
Available – Dispatch in 14 days
25 mg
CHA.29213-25mg
Price
€564.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.29213-5mg | €240.00 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.29213-25mg | €564.00 |
from Penicillium citrinum, ≥98% (HPLC), powder, mycotoxin
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C13H14O5 |
|---|---|
| CAS Number | 518-75-2 |
| Molecular Weight | 250.25 |
| NACRES | NA.77 |
| PubChem Substance ID | 24892302 |
| UNSPSC Code | 12352200 |
| EC Number | 208-257-2 |
| MDL number | MFCD00006912 |
| Beilstein/REAXYS Number | 5282243 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 200 |
Safety Information Handling visibility
| pictograms |
GHS06
GHS08
  GHS06,GHS08
|
|---|---|
| signalword | Danger |
| hcodes | H301 + H311 + H331,H351 |
| pcodes | P202 - P261 - P280 - P301 + P310 - P302 + P352 + P312 - P304 + P340 + P311 |
| Hazard Classifications | Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 2 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| wgk | WGK 3 |
| ppe | Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges |
Technical Overview & Applications Use-case context
Citrinin, with the CAS number 518-75-2, is a naturally occurring mycotoxin produced by various species of Aspergillus, Penicillium, and Monascus fungi. It was first isolated from Penicillium citrinum in 1931 and has since been found to be a common contaminant of grains, fruits, and other food products. Citrinin has been shown to exhibit nephrotoxic, hepatotoxic, and teratogenic effects in animal studies, and its toxicological profile has raised concerns regarding its potential impact on human health. The compounds mechanism of action is thought to involve the inhibition of protein synthesis and the disruption of cellular membrane function. As a result, citrinin has been the subject of extensive research aimed at understanding its biosynthesis, detection, and control, as well as its potential applications in the development of novel therapeutic agents. Further studies are needed to fully elucidate the risks and benefits associated with citrinin exposure.
